Neurocrine Biosciences
NBIX
#1542
Rank
โ‚น944.27 B
Marketcap
โ‚น9,471
Share price
-0.07%
Change (1 day)
-16.99%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Revenue for Neurocrine Biosciences (NBIX)

Revenue in 2024 (TTM): โ‚น198.09 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚น204.66 Billion. an increase over the revenue in the year 2023 that were of โ‚น157.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neurocrine Biosciences from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น202.05 B28.62%
2023 โ‚น157.09 B27.53%
2022 โ‚น123.18 B46.02%
2021 โ‚น84.36 B10.3%
2020 โ‚น76.49 B36.12%
2019 โ‚น56.19 B78.1%
2018 โ‚น31.55 B205.74%
2017 โ‚น10.31 B912.43%
2016 โ‚น1.01 B-22.41%
2015 โ‚น1.31 B
2014 N/A-100%
2013 โ‚น0.18 B-93.8%
2012 โ‚น2.90 B-28.95%
2011 โ‚น4.09 B172.8%
2010 โ‚น1.50 B995.6%
2009 โ‚น0.13 B-28.28%
2008 โ‚น0.19 B297.74%
2007 โ‚น48.03 M-97.24%
2006 โ‚น1.73 B-68.83%
2005 โ‚น5.57 B51.13%
2004 โ‚น3.68 B-41.75%
2003 โ‚น6.33 B631.76%
2002 โ‚น0.86 B-56.52%
2001 โ‚น1.98 B192.28%
2000 โ‚น0.68 B-6.83%
1999 โ‚น0.73 B7.42%
1998 โ‚น0.68 B-33.67%
1997 โ‚น1.02 B48.6%
1996 โ‚น0.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น54.10 B-73.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น196.69 B-3.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น30.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.914 T 1,812.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.895 T 2,291.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.223 T 2,452.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น48.26 B-76.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.95 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA